HIV/AIDS

Forecasting antiretroviral demand


Meetings on ARV global demand forecasting

The Secretary-General of the United Nations met with the heads of the major pharmaceutical and diagnostic companies working on HIV/AIDS in October 2008. Both the UN and the companies are committed to place the issue of AIDS high on their respective agendas for years to come. As part of its commitment, WHO HIV/AIDS Department AIDS Medicines and Diagnostics Service team - together with UNAIDS - has hosted annual technical consultations on ARV forecasting and the needs in appropriate products since 2005. The last consultation took place on 9 and 10 December 2010 in Geneva.



Joint WHO & UNAIDS informal consultation with pharmaceutical companies - forecasting global ARV demand 2011-2012
Geneva, 9&10 December 2010

WHO and UNAIDS jointly organize annually a consultation with ARV innovators and generic companies and active pharmaceutical ingredients producers. The objectives were:

  • to take stock of progress made in ART scale up and contribution made by companies in matching the increasing global ARV demand;
  • to share information on current ARV market in low and middle income countries and WHO/UNAIDS forecasts for supporting companies in the planning of their production capacity for 2011 and 2012;
  • to share latest developments in the WHO HIV/AIDS Strategy and new global initiatives including Treatment 2.0 and Elimination of Vertical Transmission;
  • to invite the major funding agencies for ART (GFATM, PEPFAR, UNITAID) to share information on the current availability of funding and funding projections.

Meeting information

Presentations

Achieving universal access

WHO & UNAIDS forecasts of ARV global demand 2011-2012

Panel on Resources for ARVs

Tools and strategic information for forecasting ARV demand

Progress update session on pharmaceutical management activities by the Global Fund To Fight AIDS, Tuberculosis and Malaria


Share